CYTEK BIOSCIENCES, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
CYTEK BIOSCIENCES, INC. (CTKB) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 1.40 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-05
- CYTEK BIOSCIENCES, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 1.40M shares, a 7.69% increase year-over-year.
- CYTEK BIOSCIENCES, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 1.60M shares, a 5.88% decline year-over-year.
- CYTEK BIOSCIENCES, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 1.30M shares, a 88.07% decline year-over-year.
- CYTEK BIOSCIENCES, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 1.70M shares, a 73.02% decline year-over-year.
- CYTEK BIOSCIENCES, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 11.10M shares, a 54.17% increase from fiscal 2024.
- CYTEK BIOSCIENCES, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 7.20M shares, a 20.00% decline from fiscal 2023.
- CYTEK BIOSCIENCES, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 9.00M shares, a 157.14% increase from fiscal 2022.
- CYTEK BIOSCIENCES, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 3.50M shares, a 52.17% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | 1.40M shares 10-Q · filed 2026-08-05 | 1.60M shares 10-Q · filed 2026-08-05 | |||
| 2026-03-31 | 1.60M shares 10-Q · filed 2026-05-07 | ||||
| 2025-12-31 | 11.10M shares 10-K · filed 2026-02-26 | ||||
| 2025-06-30 | 1.30M shares 10-Q · filed 2026-08-05 | 1.50M shares 10-Q · filed 2026-08-05 | |||
| 2025-03-31 | 1.70M shares 10-Q · filed 2026-05-07 | ||||
| 2024-12-31 | 7.20M shares 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | 9.40M shares 10-Q · filed 2024-11-07 | ||||
| 2024-06-30 | 10.90M shares 10-Q · filed 2024-08-06 | 7.10M shares 10-Q · filed 2024-08-06 | |||
| 2024-03-31 | 6.30M shares 10-Q · filed 2024-05-08 | ||||
| 2023-12-31 | 9.00M shares 10-K · filed 2026-02-26 | ||||
| 2023-09-30 | 7.20M shares 10-Q · filed 2023-11-14 | 6.20M shares 10-Q · filed 2024-11-07 | |||
| 2023-06-30 | 2.50M shares 10-Q · filed 2024-08-06 | 6.90M shares 10-Q · filed 2023-08-08 | 6.00M shares 10-Q · filed 2024-08-06 | ||
| 2023-03-31 | 4.60M shares 10-Q · filed 2024-05-08 | ||||
| 2022-12-31 | 3.50M shares 10-K · filed 2025-02-28 | ||||
| 2022-09-30 | 3.50M shares 10-Q · filed 2023-11-14 | 4.10M shares 10-Q · filed 2023-11-14 | |||
| 2022-06-30 | 4.40M shares 10-Q · filed 2023-08-08 | 3.90M shares 10-Q · filed 2023-08-08 | |||
| 2022-03-31 | 3.20M shares 10-Q · filed 2023-05-09 | ||||
| 2021-12-31 | 2.30M shares 10-K · filed 2024-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |